These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30864719)

  • 1. LncRNA‑AB209371 promotes the epithelial‑mesenchymal transition of hepatocellular carcinoma cells.
    Xiao C; Wan X; Yu H; Chen X; Shan X; Miao Y; Fan R; Cha W
    Oncol Rep; 2019 May; 41(5):2957-2966. PubMed ID: 30864719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.
    Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.
    Ye T; Xu J; Du L; Mo W; Liang Y; Xia J
    Cell Physiol Biochem; 2017; 41(4):1584-1595. PubMed ID: 28334716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSF1 promotes the inhibition of EMT-associated migration by low glucose via directly regulating Snail1 expression in HCC cells.
    Liu D; Sun L; Qin X; Liu T; Zhang S; Liu Y; Li S; Guo K
    Discov Med; 2016 Sep; 22(120):87-96. PubMed ID: 27755964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail.
    Xia W; Ma X; Li X; Dong H; Yi J; Zeng W; Yang Z
    Oncol Rep; 2015 Aug; 34(2):655-62. PubMed ID: 26035427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1.
    Yu CP; Yu S; Shi L; Wang S; Li ZX; Wang YH; Sun CJ; Liang J
    Mol Med Rep; 2017 Oct; 16(4):5181-5188. PubMed ID: 28849004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
    Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.
    Sun X; Zhao S; Li H; Chang H; Huang Z; Ding Z; Dong L; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2017 Mar; 232(3):625-634. PubMed ID: 27333771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA HOXA11‑AS accelerates cell proliferation and epithelial‑mesenchymal transition in hepatocellular carcinoma by modulating the miR‑506‑3p/Slug axis.
    Liu Y; Yan W; Zhou D; Jin G; Cheng X
    Int J Mol Med; 2020 Nov; 46(5):1805-1815. PubMed ID: 32901858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition.
    Li R; Shang R; Li S; Ren Y; Shen L; Yang L; Chen S; Chen X; Li J; Xu M
    Environ Toxicol; 2022 Oct; 37(10):2540-2551. PubMed ID: 35841383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
    Huang D; Cao L; Zheng S
    J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.